Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dbv Technologies ADR (NQ: DBVT ) 0.9325 -0.0125 (-1.32%) Streaming Delayed Price Updated: 3:45 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Dbv Technologies ADR < Previous 1 2 Next > Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 August 02, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report July 30, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results July 30, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 July 29, 2024 From DBV Technologies S.A. Via GlobeNewswire Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF July 08, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From DBV Technologies S.A. Via GlobeNewswire Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024 June 04, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Announces Plan to Implement ADS Ratio Change May 31, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in Upcoming EAACI 2024 Congress May 30, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Announces Plan to Implement ADS Ratio Change May 17, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Announces Results of its 2024 Combined General Meeting May 16, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in Upcoming Investor Conferences May 09, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Reports First Quarter 2024 Financial Results and Business Update May 07, 2024 From DBV Technologies S.A. Via GlobeNewswire Combined General Meeting of May 16, 2024 April 25, 2024 From DBV Technologies S.A. Via GlobeNewswire Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 April 04, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document March 08, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Reports Full Year 2023 Financial Results and Business Update March 07, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 March 04, 2024 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in Upcoming AAAAI 2024 Congress February 20, 2024 From DBV Technologies S.A. Via GlobeNewswire Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF January 16, 2024 From DBV Technologies S.A. Via GlobeNewswire Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023 December 04, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers November 09, 2023 From DBV Technologies S.A. Via GlobeNewswire Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023 November 06, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Present New Data at ACAAI 2023 November 02, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results October 31, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update October 27, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer October 16, 2023 From DBV Technologies S.A. Via GlobeNewswire Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023 October 05, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in Upcoming Investor Conference September 05, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results July 31, 2023 From DBV Technologies S.A. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.